Semnur Pharmaceuticals, Inc. Revenue, Remaining Performance Obligation, Percentage
Semnur Pharmaceuticals, Inc. (SMNR) had Revenue, Remaining Performance Obligation, Percentage of 100.00% as of 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Notes
us-gaap:RevenueRemainingPerformanceObligationPercentage · last filed 2023-11-09
- 2023-09-30: Revenue, Remaining Performance Obligation, Percentage 100.00%.
| Period end | Revenue, Remaining Performance Obligation, Percentage |
|---|---|
| 2023-09-30 | 100.00% 10-Q · filed 2023-11-09 |